Related Experiment Video
Updated: Jul 29, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism
James M McFarland1, Brenton R Paolella1, Allison Warren1
1Broad Institute of MIT and Harvard, Cambridge, 021242, MA, USA.
Abstract:
Assays to study cancer cell responses to pharmacologic or genetic perturbations are typically restricted to using simple phenotypic readouts such as proliferation rate. Information-rich assays, such as gene-expression profiling, have generally not permitted efficient profiling of a given perturbation across multiple cellular contexts. Here, we develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation responses across a mixture of samples with single-cell resolution, using SNP-based computational demultiplexing of single-cell RNA-sequencing data. We show that MIX-Seq can be used to profile responses to chemical or genetic perturbations across pools of 100 or more cancer cell lines. We combine it with Cell Hashing to further multiplex additional experimental conditions, such as post-treatment time points or drug doses. Analyzing the high-content readout of scRNA-seq reveals both shared and context-specific transcriptional response components that can identify drug mechanism of action and enable prediction of long-term cell viability from short-term transcriptional responses to treatment.
Insights
This study introduces MIX-Seq, a novel method for analyzing cancer cell responses across many cell lines simultaneously. MIX-Seq uses single-cell RNA sequencing to reveal detailed gene expression changes, aiding drug discovery and treatment prediction.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Traditional cancer cell response assays rely on limited phenotypic readouts like proliferation.
- Information-rich methods like gene-expression profiling are inefficient for multi-context perturbation studies.
Purpose of the Study:
- To develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation cancer cell responses.
- To enable single-cell resolution analysis across a mixture of samples for comprehensive perturbation studies.
Main Methods:
- MIX-Seq utilizes SNP-based computational demultiplexing of single-cell RNA sequencing (scRNA-seq) data.
- The method allows profiling responses across pooled cancer cell lines (100+).
- Cell Hashing is combined with MIX-Seq to multiplex additional experimental variables like time points or drug doses.
Main Results:
- MIX-Seq successfully profiled responses to chemical and genetic perturbations in large pools of cancer cell lines.
- Analysis of high-content scRNA-seq data revealed shared and context-specific transcriptional response patterns.
- These patterns identified drug mechanisms of action and predicted long-term cell viability from short-term responses.
Conclusions:
- MIX-Seq offers an efficient approach for high-content transcriptional profiling of cancer cell responses.
- The method facilitates the discovery of drug mechanisms and prediction of treatment outcomes.
- This advancement supports personalized medicine by enabling detailed analysis of drug effects in diverse cellular contexts.
More Related Videos
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020